Kamada Ltd. (NASDAQ:KMDA, TASE: KMDA.TA))), a global biopharmaceutical company with a portfolio of m

Company Expects Growing Biosimilar Product Portfolio, Commercialized in Israel and the MENA Region,

Kamada (NASDAQ: KMDA) outlined its growth strategy, product portfolio and financial outlook during a

Kamada NASDAQ: KMDA outlined its growth strategy, product portfolio and financial outlook during a c

U.S. Centers for Disease Control and Prevention (CDC) Reports a Significant Year-Over-Year Increase

REHOVOT, Israel, and HOBOKEN, N.J., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TA

REHOVOT, Israel and HOBOKEN, N.J., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (the “Company”) (N

Dividend to be Paid Consistent with the Company's Cash Dividend Policy Dividend to be Paid Consisten

Kamada (KMDA) possesses solid growth attributes, which could help it handily outperform the market.

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Kamada (KM

The consensus price target hints at a 79.1% upside potential for Kamada (KMDA). While empirical rese

Kamada Ltd. (KMDA) Q2 2026 Earnings Call Transcript

Although the revenue and EPS for Kamada (KMDA) give a sense of how its business performed in the qua

Kamada (KMDA) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estim

Kamada (NASDAQ:KMDA) affirms FY2026 sales outlook from $200.000 million-$205.000 million to $200.000

Kamada (NASDAQ:KMDA) reported quarterly earnings of $0.16 per share which beat the analyst consensus

REHOVOT, Israel and HOBOKEN, N.J., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE

REHOVOT, Israel, and HOBOKEN, N.J., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TAS

REHOVOT, Israel, and HOBOKEN, N.J., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd.

Kamada (NASDAQ: KMDA - Get Free Report) and InflaRx (NASDAQ: IFRX - Get Free Report) are both small-

Kamada Ltd. (NASDAQ:KMDA, TASE: KMDA.TA))), a global biopharmaceutical company with a portfolio of m

REHOVOT, Israel and HOBOKEN, N.J., July 20, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd.

Kamada Ltd. (NASDAQ:KMDA, TASE: KMDA.TA))), a global biopharmaceutical company with a portfolio of m

Findings from analyses of CMV high-risk lung transplant recipients suggest CYTOGAM use is associated

Kamada Ltd. (NASDAQ:KMDA, TASE: KMDA.TA))), a global biopharmaceutical company with a portfolio of m

REHOVOT, Israel and HOBOKEN, N.J., June 01, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE

Kamada (NASDAQ:KMDA) affirms FY2026 sales outlook from $200.000 million-$205.000 million to $200.000

Kamada (NASDAQ:KMDA) reported quarterly earnings of $0.07 per share which missed the analyst consens

Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its

Companies Reporting Before The Bell • Wix.com (NASDAQ:WIX) is likely to report quarterly earnings a

Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly

  On Thursday, 241 companies hit new 52-week lows.

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for

  On Wednesday, 215 companies set new 52-week lows.

  On Friday, 1043 companies hit new 52-week lows.

  Companies Reporting Before The Bell • IDEAYA Biosciences (NASDAQ:IDYA) is likely to report quart

  Companies Reporting Before The Bell • Wireless Telecom Group (AMEX:WTT) is likely to report earn

  Companies Reporting Before The Bell • PolyPid (NASDAQ:PYPD) is estimated to report earnings for

Gainers Albireo Pharma, Inc. (NASDAQ: ALBO) shares climbed 42.5% to $39.00 as the company disclos

During Monday's morning session, 127 stocks hit new 52-week highs.